These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23694867)

  • 1. Effect of platelet inhibition on bleeding complications in trauma patients on preinjury clopidogrel.
    Short S; Kram B; Taylor S; Cheng J; Ali K; Vasquez D
    J Trauma Acute Care Surg; 2013 Jun; 74(6):1419-24. PubMed ID: 23694867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
    Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
    Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
    Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuisance and alarming bleeding do not correlate with on-treatment platelet reactivity.
    Gaglia MA; Torguson R; Pokharel S; Pakala R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2013; 14(2):76-80. PubMed ID: 23375617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.
    Becker RC; Bassand JP; Budaj A; Wojdyla DM; James SK; Cornel JH; French J; Held C; Horrow J; Husted S; Lopez-Sendon J; Lassila R; Mahaffey KW; Storey RF; Harrington RA; Wallentin L
    Eur Heart J; 2011 Dec; 32(23):2933-44. PubMed ID: 22090660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles and issues of P2Y12 percent inhibition assessed by VerifyNow assay for patients undergoing Neurointervention: a prospective study.
    Kashiwazaki D; Kuwayama N; Akioka N; Hayakawa Y; Kuroda S
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1830-6. PubMed ID: 24957307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery.
    Collinge CA; Kelly KC; Little B; Weaver T; Schuster RD
    J Orthop Trauma; 2012 Oct; 26(10):568-73. PubMed ID: 22441640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
    Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
    Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients.
    Bonville DJ; Ata A; Jahraus CB; Arnold-Lloyd T; Salem L; Rosati C; Stain SC
    Surgery; 2011 Oct; 150(4):861-8. PubMed ID: 22000201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new clopidogrel (Plavix) point-of-care assay: rapid determination of antiplatelet activity in trauma patients.
    Bansal V; Fortlage D; Lee J; Doucet J; Potenza B; Coimbra R
    J Trauma; 2011 Jan; 70(1):65-9; discussion 69-70. PubMed ID: 21217483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery.
    Karabulut H; Toraman F; Evrenkaya S; Goksel O; Tarcan S; Alhan C
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):419-23. PubMed ID: 15019671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy.
    Storey RF; Angiolillo DJ; Patil SB; Desai B; Ecob R; Husted S; Emanuelsson H; Cannon CP; Becker RC; Wallentin L
    J Am Coll Cardiol; 2010 Oct; 56(18):1456-62. PubMed ID: 20832963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.
    Bal Dit Sollier C; Berge N; Boval B; Dubar M; Drouet L
    Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements.
    Filsoufi F; Rahmanian PB; Castillo JG; Kahn RA; Fischer G; Adams DH
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):60-6. PubMed ID: 18249332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity.
    Capranzano P; Tamburino C; Capodanno D; Miccichè E; D'Urso L; Calvi V; Angiolillo DJ; Tamburino C
    Thromb Haemost; 2011 Dec; 106(6):1149-57. PubMed ID: 22011914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
    Khurram Z; Chou E; Minutello R; Bergman G; Parikh M; Naidu S; Wong SC; Hong MK
    J Invasive Cardiol; 2006 Apr; 18(4):162-4. PubMed ID: 16729401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses.
    Storey RF; Bliden KP; Ecob R; Karunakaran A; Butler K; Wei C; Tantry U; Gurbel PA
    J Thromb Haemost; 2011 Sep; 9(9):1730-7. PubMed ID: 21707911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy.
    Angiolillo DJ; Capranzano P; Ferreiro JL; Ueno M; Capodanno D; Dharmashankar K; Darlington A; Sumner S; Desai B; Charlton RK; Box LC; Zenni M; Guzman LA; Bass TA
    Thromb Haemost; 2011 Aug; 106(2):253-62. PubMed ID: 21614414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.